Recent Quotes (30 days)

You have no recent quotes
chg | %

DDD Group Plc news

   Watch this stock
Showing stories 1 - 1 of about 1   

Articles published

DDD 2.01 -0.61 (-23.33%)
price chart
Benvenue Medical Secures $25 Million Series D Financing
The spine company intends to use the proceeds to sustain global commercialization of its three breakthrough minimally invasive products to treat degenerative disc disease (DDD) with spinal fusion and vertebral compression fractures (VCFs), as well as ...
Related articles »